Estrogens and falling sperm counts

2001 ◽  
Vol 13 (4) ◽  
pp. 317 ◽  
Author(s):  
D. J. Handelsman

Extravagant claims have been made repeatedly in recent years that human sperm counts are falling and that global exposure to environmental estrogens are responsible. The basis for these two distinct claims is reviewed. The claims of falling human sperm output, reviving an old debate, are prompted by a paper by Carlsen et al. (1992). This meta-analysis, however, is marred by numerous flaws that invalidate its claims. Major defects include severe heterogeneity of component studies, rendering them unsuitable for aggregation, and defective data analysis based on arithmetic mean rather than median, which showed no significant changes over time. This debate is likely to remain unresolved until valid, representative population-based studies of human sperm output can be achieved. None have been reported, or seem feasible in the near future, and so alternative strategies, based on surrogate variables for human male fertility not requiring sperm counts, need to be developed and validated. The plausible hypothesis that prenatal estrogen exposure might influence development of the human testis through effects on Sertoli cell replication and sperm carrying capacity has, however, been conclusively refuted by studies of boys born to women exposed to high doses of oral diethylstilbestrol during pregnancy. Neither fertility nor sperm output were adversely influenced by massive maternal estrogen exposure during pregnancy, although minor urogenital malformations did occur. The still wider claims of deteriorating male reproductive health, notably changes in prevalence or incidence of hypospadias or cryptorchidism, also lack convincing population-based evidence, although cancer registry data indicate a gradual increase in testis cancer in some countries. In summary, the available evidence does not support claims of falling sperm counts or any general deterioration in male reproductive health. Population-based studies of valid surrogate variables for male fertility not requiring semen analysis are needed. If population-based evidence regarding male fertility or sperm output could be generated, it is highly unlikely that prenatal estrogen exposure could be a valid explanation of any deterioration as massive maternal exposure to oral estrogen has negligible effects on male fertility or sperm output.

2021 ◽  
Vol 2 ◽  
pp. 13
Author(s):  
Shilpi Singh ◽  
Shio Kumar Singh

Perfluoroalkyl substances (PFASs) are a group of synthetic organic chemicals that are persistent in the environment as well as in wildlife and human body. Further, PFASs are considered as persistent organic pollutants. PFASs have been extensively used in many industrial and consumer products over the past several decades and, therefore, they are found in various environmental matrices. A large number of studies during the past decades have reported the toxic effects of these compounds on the male reproductive health including damage to the seminiferous tubules, changes in reproductive hormones level, and low sperm counts and the molecular mechanism(s) involved in such effects. In the present review, we have summarized the reproductive toxicity of some PFASs, namely, perfluorooctanoic acid, perfluorooctane sulfonate, perfluorododecanoic acid, and perfluorononanoic acid in the male. This article briefly describes the findings on PFASs which may attract the attention of the reproductive toxicologists to examine the potential risk to the male reproductive health because of the continued contamination of the environment by these compounds.


Antioxidants ◽  
2021 ◽  
Vol 10 (9) ◽  
pp. 1365 ◽  
Author(s):  
Sara C. Pereira ◽  
Pedro F. Oliveira ◽  
Sónia Rodrigues Oliveira ◽  
Maria de Lourdes Pereira ◽  
Marco G. Alves

Male reproductive tissues are strongly susceptible to several environmental and lifestyle stressors. In general, male reproductive health is highly sensitive to oxidative stress, which results in reversible and/or irreversible changes in testosterone-producing cells, spermatogenesis, and sperm quality. Chromium compounds are widely used in the +3 and +6 valence states, as food supplements, and in the industrial field, respectively. Chromium (III) compounds, i.e., Cr(III)-tris-picolinate, [Cr(pic)3], known as chromium picolinate, are used as nutritional supplements for the control of diabetes, body weight, and muscular growth. However, previous studies showed that animal models exposed to chromium picolinate experienced degenerative changes in spermatogenesis. Contradictory results are documented in the literature and deserve discussion. Furthermore, the long-term effects of chromium picolinate on the antioxidant system of treated subjects have not been properly studied. Comprehensive studies on the role of this compound will help to establish the safe and useful use of chromium supplementation. On the other hand, chromium (VI) compounds are widely used in several industries, despite being well-known environmental pollutants (i.e., welding fumes). Chromium (VI) is known for its deleterious effects on male reproductive health as toxic, carcinogenic, and mutagenic. Previous studies have demonstrated severe lesions to mouse spermatogenesis after exposure to chromium (VI). However, workers worldwide are still exposed to hexavalent chromium, particularly in electronics and military industries. Data from the literature pinpoints mechanisms of oxidative stress induced by chromium compounds in somatic and germ cells that lead to apoptosis, thus underlining the impairment of fertility potential. In this review, we analyze the benefits and risks of chromium compounds on male fertility, as well as the mechanisms underlying (in)fertility outcomes. Although supplements with antioxidant properties may maximize male fertility, adverse effects need to be investigated and discussed.


Author(s):  
Aleksander Giwercman

Male patients referred for infertility problems are often curious as to whether their problem may be caused by environmental influences, and thus whether their chances of becoming a father can be increased by a change in lifestyle or occupation. The present level of knowledge does not allow a definitive, evidence based recommendation to be made. Except for some very few, rather extreme, occupational (e.g. 1,2-dibromo-3-chloropropane; DBCP) or iatrogenic (e.g. irradiation, cytotoxic drugs) exposures known to cause temporary or even permanent sterility, it is difficult to point to specific environmental influences as definite causes of male infertility. Nevertheless, recent research has generated some interesting information regarding the possible impact of the environment on male reproductive functions (1). This research was stimulated by reports on a possible time-related decline in male fertility (2)—a question still remaining controversial. However, there is now a considerable amount of information showing that environmental and lifestyle related exposure during early fetal development is of crucial importance for reproductive health in adult life (3).


Apmis ◽  
2001 ◽  
Vol 109 (S103) ◽  
pp. S48-S61 ◽  
Author(s):  
PIERRE JOUANNET ◽  
CHRISTINA WANG ◽  
FLORENCE EUSTACHE ◽  
TINA KOLD-JENSEN ◽  
JACQUES AUGER

2019 ◽  
Vol 20 (3) ◽  
pp. 27-35
Author(s):  
T. M. Sorokina ◽  
M. V. Andreeva ◽  
V. B. Chernykh ◽  
L. F. Kurilo

Varicocele is one of the most common diseases of the male reproductive system. Despite the high prevalence of this pathology, the effect of varicocele on male fertility is still a controversial issue. Opinions of experts about the possible effects of varicocele on the male reproductive health, the causes and methods of treatment are contradictory, and the experimental data obtained often show directly opposed results. This article presents a review of the literature on the effects of varicocele on the male reproductive system and fertility.


Apmis ◽  
2001 ◽  
Vol 109 (5) ◽  
pp. 333-344 ◽  
Author(s):  
Pierre Jouannet ◽  
Christina Wang ◽  
Florence Eustache ◽  
Tina Kold-Jensen ◽  
Jacques Auger

2020 ◽  
Vol 21 (1) ◽  
Author(s):  
Melanie K. Stewart ◽  
Deidre M. Mattiske ◽  
Andrew J. Pask

Abstract Background The increasing incidence of reproductive disorders in humans has been attributed to in utero exposure to estrogenic endocrine disruptors. In particular, exposure of the developing testis to exogenous estrogen can negatively impact male reproductive health. To determine how estrogens impact human gonad function, we treated the human testis-derived cell line NT2/D1 with estrogen and examined its impact on SOX9 and the expression of key markers of granulosa (ovarian) and Sertoli (testicular) cell development. Results Estrogen successfully activated its cognate receptor (estrogen receptor alpha; ESR1) in NT2/D1 cells. We observed a significant increase in cytoplasmic SOX9 following estrogen treatment. After 48 h of estrogen exposure, mRNA levels of the key Sertoli cell genes SOX9, SRY, AMH, FGF9 and PTGDS were significantly reduced. This was followed by a significant increase in mRNA levels for the key granulosa cell genes FOXL2 and WNT4 after 96 h of estrogen exposure. Conclusions These results are consistent with estrogen's effects on marsupial gonads and show that estrogen has a highly conserved impact on gonadal cell fate decisions that has existed in mammals for over 160 million years. This effect of estrogen presents as a potential mechanism contributing to the significant decrease in male fertility and reproductive health reported over recent decades. Given our widespread exposure to estrogenic endocrine disruptors, their effects on SOX9 and Sertoli cell determination could have considerable impact on the adult testis.


2020 ◽  
Vol 26 (11) ◽  
pp. 816-824
Author(s):  
Anders Rehfeld

ABSTRACT The sperm-specific Ca2+ channel CatSper (cation channel of sperm) is vital for male fertility. Contradictory findings have been published on the regulation of human CatSper by the endogenous steroids estradiol, testosterone and hydrocortisone, as well as the plant triterpenoids, lupeol and pristimerin. The aim of this study was to elucidate this controversy by investigating the action of these steroids and plant triterpenoids on human CatSper using population-based Ca2+-fluorimetric measurements, the specific CatSper-inhibitor RU1968 and a functional test assessing the CatSper-dependent penetration of human sperm cells into methylcellulose. Estradiol, testosterone and hydrocortisone were found to induce Ca2+-signals in human sperm cells with EC50 values in the lower μM range. By employing the specific CatSper-inhibitor RU1968, all three steroids were shown to induce Ca2+-signals through an action on CatSper, similar to progesterone. The steroids were found to dose-dependently inhibit subsequent progesterone-induced Ca2+-signals with IC50 values in the lower μM range. Additionally, the three steroids were found to significantly increase the penetration of human sperm cells into methylcellulose, similar to the effect of progesterone. The two plant triterpenoids, lupeol and pristimerin, were unable to inhibit progesterone-induced Ca2+-signals, whereas the CatSper-inhibitor RU1968 strongly inhibited progesterone-induced Ca2+-signals. In conclusion, this study supports the claim that the steroids estradiol, testosterone and hydrocortisone act agonistically on CatSper in human sperm cells, thereby mimicking the effect of progesterone, and that lupeol and pristimerin do not act as inhibitors of human CatSper.


Sign in / Sign up

Export Citation Format

Share Document